3D Porous Chitosan-Alginate Scaffolds as an in Vitro Model for Evaluating Nanoparticle-Mediated Tumor Targeting and Gene Delivery to Prostate Cancer

Biomacromolecules

Volumn 16, Issue 10, 2015, Pages 3362-3372

  Wang, Kui ^a   Kievit, Forrest M ^b   Florczyk, Stephen J ^a,c   Stephen, Zachary R ^a   Zhang, Miqin ^a,b  

^a University of Washington   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c University of Central Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; CELLS; CHITIN; CHITOSAN; CYTOLOGY; DISEASES; GENE EXPRESSION; GENE TRANSFER; GENES; NANOPARTICLES; TUMORS; UROLOGY;

CATIONIC NANOPARTICLES; CHITOSAN ALGINATES; POROUS SCAFFOLD; PROSTATE CANCERS; TARGETED DELIVERY; TARGETED GENE DELIVERY; THREEDIMENSIONAL (3-D); TUMOR MICROENVIRONMENT;

SCAFFOLDS (BIOLOGY);

ALGINIC ACID; CHITOSAN; MOLECULAR SCAFFOLD; GLUCURONIC ACID; HEXURONIC ACID; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SYNTHESIS; GENE EXPRESSION; IN VITRO GENE TRANSFER; IN VITRO STUDY; IN VIVO GENE TRANSFER; MALE; MARKER GENE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR SPHEROID; ANIMAL; CHEMISTRY; FEMALE; GENE THERAPY; HUMAN; POROSITY; PROSTATIC NEOPLASMS;

ALGINATES; ANIMALS; CHITOSAN; FEMALE; GENETIC THERAPY; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; IN VITRO TECHNIQUES; MALE; MICE; NANOPARTICLES; POROSITY; PROSTATIC NEOPLASMS;

EID: 84944112089     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/acs.biomac.5b01032     Document Type: Article

References (88)

1. Siegel, R.; Ma, J.; Zou, Z.; Jemal, A. Cancer statistics, 2014 Ca-Cancer J. Clin. 2014, 64 (1) 9-29 10.3322/caac.21208
2. Heidenreich, A.; Bellmunt, J.; Bolla, M.; Joniau, S.; Mason, M.; Matveev, V.; Mottet, N.; Schmid, H. P.; van der Kwast, T.; Wiegel, T.; Zattoni, F. EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease Eur. Urol. 2011, 59 (1) 61-71 10.1016/j.eururo.2010.10.039
3. Zelefsky, M. J.; Fuks, Z.; Hunt, M.; Yamada, Y.; Marion, C.; Ling, C. C.; Amols, H.; Venkatraman, E. S.; Leibel, S. A. High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients Int. J. Radiat. Oncol., Biol., Phys. 2002, 53 (5) 1111-1116 10.1016/S0360-3016(02)02857-2
4. Kuban, D. A.; Tucker, S. L.; Dong, L.; Starkschall, G.; Huang, E. E.; Cheung, M. R.; Lee, A. K.; Pollack, A. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer Int. J. Radiat. Oncol., Biol., Phys. 2008, 70 (1) 67-74 10.1016/j.ijrobp.2007.06.054
5. Djavan, B.; Nasu, Y. Prostate cancer gene therapy-what have we learned and where are we going? Rev. Urol 2001, 3 (4) 179-86
6. Schenk, E.; Essand, M.; Bangma, C. H.; Barber, C.; Behr, J. P.; Briggs, S.; Carlisle, R.; Cheng, W. S.; Danielsson, A.; Dautzenberg, I. J.; Dzojic, H.; Erbacher, P.; Fisher, K.; Frazier, A.; Georgopoulos, L. J.; Hoeben, R.; Kochanek, S.; Koppers-Lalic, D.; Kraaij, R.; Kreppel, F.; Lindholm, L.; Magnusson, M.; Maitland, N.; Neuberg, P.; Nilsson, B.; Ogris, M.; Remy, J. S.; Scaife, M.; Schooten, E.; Seymour, L.; Totterman, T.; Uil, T. G.; Ulbrich, K.; Veldhoven-Zweistra, J. L.; de Vrij, J.; van Weerden, W.; Wagner, E.; Willemsen, R. Clinical adenoviral gene therapy for prostate cancer Hum. Gene Ther. 2010, 21 (7) 807-13 10.1089/hum.2009.206
7. Flintoft, L. Gene therapy: Gene editors deliver Nat. Rev. Genet. 2007, 8 (12) 908-909 10.1038/nrg2281
8. Freytag, S. O.; Movsas, B.; Aref, I.; Stricker, H.; Peabody, J.; Pegg, J.; Zhang, Y.; Barton, K. N.; Brown, S. L.; Lu, M.; Savera, A.; Kim, J. H. Phase I Trial of Replication-competent Adenovirus-mediated Suicide Gene Therapy Combined with IMRT for Prostate Cancer Mol. Ther. 2007, 15 (5) 1016-1023 10.1038/mt.sj.6300120
9. Harrington, K. J.; Spitzweg, C.; Bateman, A. R.; Morris, J. C.; Vile, R. G. Gene therapy for prostate cancer: Current status and future prospects J. Urol. 2001, 166 (4) 1220-1233 10.1016/S0022-5347(05)65742-4
10. Steiner, M. S.; Gingrich, J. R. Gene therapy for prostate cancer: Where are we now? J. Urol. 2000, 164 (4) 1121-1136 10.1016/S0022-5347(05)67127-3
11. Boisselier, E.; Astruc, D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity Chem. Soc. Rev. 2009, 38 (6) 1759-1782 10.1039/b806051g
12. Gao, X. H.; Cui, Y. Y.; Levenson, R. M.; Chung, L. W. K.; Nie, S. M. In vivo cancer targeting and imaging with semiconductor quantum dots Nat. Biotechnol. 2004, 22 (8) 969-976 10.1038/nbt994
13. Kievit, F. M.; Veiseh, O.; Fang, C.; Bhattarai, N.; Lee, D.; Ellenbogen, R. G.; Zhang, M. Chlorotoxin Labeled Magnetic Nanovectors for Targeted Gene Delivery to Glioma ACS Nano 2010, 4 (8) 4587-4594 10.1021/nn1008512
14. Kievit, F. M.; Zhang, M. Surface Engineering of Iron Oxide Nanoparticles for Targeted Cancer Therapy Acc. Chem. Res. 2011, 44 (10) 853-862 10.1021/ar2000277
15. Yamada, K. M.; Cukierman, E. Modeling tissue morphogenesis and cancer in 3D Cell 2007, 130 (4) 601-610 10.1016/j.cell.2007.08.006
16. Pampaloni, F.; Reynaud, E. G.; Stelzer, E. H. K. The third dimension bridges the gap between cell culture and live tissue Nat. Rev. Mol. Cell Biol. 2007, 8 (10) 839-845 10.1038/nrm2236
17. Fischbach, C.; Chen, R.; Matsumoto, T.; Schmelzle, T.; Brugge, J. S.; Polverini, P. J.; Mooney, D. J. Engineering tumors with 3D scaffolds Nat. Methods 2007, 4 (10) 855-860 10.1038/nmeth1085
18. Malafaya, P. B.; Silva, G. A.; Reis, R. L. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications Adv. Drug Delivery Rev. 2007, 59 (4-5) 207-233 10.1016/j.addr.2007.03.012
19. Chia, S. L.; Tay, C. Y.; Setyawati, M. I.; Leong, D. T. Biomimicry 3D Gastrointestinal Spheroid Platform for the Assessment of Toxicity and Inflammatory Effects of Zinc Oxide Nanoparticles Small 2015, 11 (6) 702-712 10.1002/smll.201401915
20. Leong, D. T.; Ng, K. W. Probing the relevance of 3D cancer models in nanomedicine research Adv. Drug Delivery Rev. 2014, 79-80, 95-106 10.1016/j.addr.2014.06.007
21. Astashkina, A. I.; Jones, C. F.; Thiagarajan, G.; Kurtzeborn, K.; Ghandehari, H.; Brooks, B. D.; Grainger, D. W. Nanoparticle toxicity assessment using an in vitro 3-D kidney organoid culture model Biomaterials 2014, 35 (24) 6323-6331 10.1016/j.biomaterials.2014.04.060
22. Kievit, F. M.; Florczyk, S. J.; Leung, M. C.; Veiseh, O.; Park, J. O.; Disis, M. L.; Zhang, M. Chitosan-alginate 3D scaffolds as a mimic of the glioma tumor microenvironment Biomaterials 2010, 31 (22) 5903-5910 10.1016/j.biomaterials.2010.03.062
23. Florczyk, S. J.; Liu, G.; Kievit, F. M.; Lewis, A. M.; Wu, J. D.; Zhang, M. 3D Porous Chitosan-Alginate Scaffolds: A New Matrix for Studying Prostate Cancer Cell-Lymphocyte Interactions In Vitro Adv. Healthcare Mater. 2012, 1 (5) 590-599 10.1002/adhm.201100054
24. Phan-Lai, V.; Florczyk, S. J.; Kievit, F. M.; Wang, K.; Gad, E.; Disis, M. L.; Zhang, M. Three-Dimensional Scaffolds to Evaluate Tumor Associated Fibroblast-Mediated Suppression of Breast Tumor Specific T Cells Biomacromolecules 2013, 14 (5) 1330-1337 10.1021/bm301928u
25. Leung, M.; Kievit, F.; Florczyk, S.; Veiseh, O.; Wu, J.; Park, J.; Zhang, M. Chitosan-Alginate Scaffold Culture System for Hepatocellular Carcinoma Increases Malignancy and Drug Resistance Pharm. Res. 2010, 27 (9) 1939-1948 10.1007/s11095-010-0198-3
26. Kievit, F. M.; Florczyk, S. J.; Leung, M. C.; Wang, K.; Wu, J. D.; Silber, J. R.; Ellenbogen, R. G.; Lee, J. S.; Zhang, M. Proliferation and enrichment of CD133(+) glioblastoma cancer stem cells on 3D chitosan-alginate scaffolds Biomaterials 2014, 35 (33) 9137-43 10.1016/j.biomaterials.2014.07.037
27. Muzzarelli, R. A. A. Chitosan composites with inorganics, morphogenetic proteins and stem cells, for bone regeneration Carbohydr. Polym. 2011, 83 (4) 1433-1445 10.1016/j.carbpol.2010.10.044
28. Rinaudo, M. Main properties and current applications of some polysaccharides as biomaterials Polym. Int. 2008, 57 (3) 397-430 10.1002/pi.2378
29. Scott, J. E. Supramolecular organization of extracellular matrix glycosaminoglycans, in vitro and in the tissues Faseb J. 1992, 6 (9) 2639-2645
30. Strack, R. L.; Strongin, D. E.; Bhattacharyya, D.; Tao, W.; Berman, A.; Broxmeyer, H. E.; Keenan, R. J.; Glick, B. S. A noncytotoxic DsRed variant for whole-cell labeling Nat. Methods 2008, 5 (11) 955-957 10.1038/nmeth.1264
31. Li, Z. S.; Ramay, H. R.; Hauch, K. D.; Xiao, D. M.; Zhang, M. Q. Chitosan-alginate hybrid scaffolds for bone tissue engineering Biomaterials 2005, 26 (18) 3919-3928 10.1016/j.biomaterials.2004.09.062
32. Kievit, F. M.; Veiseh, O.; Bhattarai, N.; Fang, C.; Gunn, J. W.; Lee, D.; Ellenbogen, R. G.; Olson, J. M.; Zhang, M. PEI-PEG-Chitosan-Copolymer-Coated Iron Oxide Nanoparticles for Safe Gene Delivery: Synthesis, Complexation, and Transfection Adv. Funct. Mater. 2009, 19 (14) 2244-2251 10.1002/adfm.200801844
33. Bhattarai, N.; Ramay, H. R.; Gunn, J.; Matsen, F. A.; Zhang, M. PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release J. Controlled Release 2005, 103 (3) 609-624 10.1016/j.jconrel.2004.12.019
34. Carmell, M. A.; Girard, A.; van de Kant, H. J. G.; Bourc'his, D.; Bestor, T. H.; de Rooij, D. G.; Hannon, G. J. MIWI2 Is Essential for Spermatogenesis and Repression of Transposons in the Mouse Male Germline Dev. Cell 2007, 12 (4) 503-514 10.1016/j.devcel.2007.03.001
35. Matsubara, T.; Kida, K.; Yamaguchi, A.; Hata, K.; Ichida, F.; Meguro, H.; Aburatani, H.; Nishimura, R.; Yoneda, T. BMP2 Regulates Osterix through Msx2 and Runx2 during Osteoblast Differentiation J. Biol. Chem. 2008, 283 (43) 29119-29125 10.1074/jbc.M801774200
36. Shannon, M. B.; Patton, B. L.; Harvey, S. J.; Miner, J. H. A Hypomorphic Mutation in the Mouse Laminin α5 Gene (Lama5) Causes Polycystic Kidney Disease J. Am. Soc. Nephrol. 2006, 17 (7) 1913-1922 10.1681/ASN.2005121298
37. Cooke, V. G.; LeBleu, V. S.; Keskin, D.; Khan, Z.; O'Connell, J. T.; Teng, Y.; Duncan, M. B.; Xie, L.; Maeda, G.; Vong, S.; Sugimoto, H.; Rocha, R. M.; Damascena, A.; Brentani, R. R.; Kalluri, R. Pericyte Depletion Results in Hypoxia-Associated Epithelial-to-Mesenchymal Transition and Metastasis Mediated by Met Signaling Pathway Cancer Cell 2012, 21 (1) 66-81 10.1016/j.ccr.2011.11.024
38. Sánchez-Duffhues, G.; de Vinuesa, A. G.; Lindeman, J. H.; Mulder-Stapel, A.; DeRuiter, M. C.; Van Munsteren, C.; Goumans, M.-J.; Hierck, B. P.; ten Dijke, P. SLUG Is Expressed in Endothelial Cells Lacking Primary Cilia to Promote Cellular Calcification Arterioscler., Thromb., Vasc. Biol. 2015, 35 (3) 616-627 10.1161/ATVBAHA.115.305268
39. Ritson, S. A. Transcriptional Regulation of Junctional Adhesion Molecule 2 by E-Cadherin in Mouse Embryonic Stem Cells. Thesis, The University of Manchester, Manchester, U.K., 2011.
40. de Vries, W. N.; Evsikov, A. V.; Haac, B. E.; Fancher, K. S.; Holbrook, A. E.; Kemler, R.; Solter, D.; Knowles, B. B. Maternal β-catenin and E-cadherin in mouse development Development 2004, 131 (18) 4435-4445 10.1242/dev.01316
41. Bissell, M. J.; Hines, W. C. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression Nat. Med. 2011, 17 (3) 320-329 10.1038/nm.2328
42. Hutmacher, D. W. Biomaterials offer cancer research the third dimension Nat. Mater. 2010, 9 (2) 90-93 10.1038/nmat2619
43. Kelm, J. M.; Timmins, N. E.; Brown, C. J.; Fussenegger, M.; Nielsen, L. K. Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types Biotechnol. Bioeng. 2003, 83 (2) 173-180 10.1002/bit.10655
44. Ong, S.-M.; Zhao, Z.; Arooz, T.; Zhao, D.; Zhang, S.; Du, T.; Wasser, M.; van Noort, D.; Yu, H. Engineering a scaffold-free 3D tumor model for in vitro drug penetration studies Biomaterials 2010, 31 (6) 1180-1190 10.1016/j.biomaterials.2009.10.049
45. Ivascu, A.; Kubbies, M. Rapid Generation of Single-Tumor Spheroids for High-Throughput Cell Function and Toxicity Analysis J. Biomol. Screening 2006, 11 (8) 922-932 10.1177/1087057106292763
46. Barrila, J.; Radtke, A. L.; Crabbé, A.; Sarker, S. F.; Herbst-Kralovetz, M. M.; Ott, C. M.; Nickerson, C. A. Organotypic 3D cell culture models: using the rotating wall vessel to study host-pathogen interactions Nat. Rev. Microbiol. 2010, 8 (11) 791-801 10.1038/nrmicro2423
47. Pickl, M.; Ries, C. H. Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab Oncogene 2009, 28 (3) 461-468 10.1038/onc.2008.394
48. Harma, V.; Virtanen, J.; Makela, R.; Happonen, A.; Mpindi, J.-P.; Knuuttila, M.; Kohonen, P.; Lotjonen, J.; Kallioniemi, O.; Nees, M. A Comprehensive Panel of Three-Dimensional Models for Studies of Prostate Cancer Growth, Invasion and Drug Responses PLoS One 2010, 5 (5) e10431 10.1371/journal.pone.0010431
49. Chignola, R.; Schenetti, A.; Andrighetto, G.; Chiesa, E.; Foroni, R.; Sartoris, S.; Tridente, G.; Liberati, D. Forecasting the growth of multicell tumour spheroids: implications for the dynamic growth of solid tumours Cell Proliferation 2000, 33 (4) 219-229 10.1046/j.1365-2184.2000.00174.x
50. Lu, P.; Weaver, V. M.; Werb, Z. The extracellular matrix: A dynamic niche in cancer progression J. Cell Biol. 2012, 196 (4) 395-406 10.1083/jcb.201102147
51. Davis, G. E.; Senger, D. R. Endothelial extracellular matrix-Biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization Circ. Res. 2005, 97 (11) 1093-1107 10.1161/01.RES.0000191547.64391.e3
52. Lee, G. Y.; Kenny, P. A.; Lee, E. H.; Bissell, M. J. Three-dimensional culture models of normal and malignant breast epithelial cells Nat. Methods 2007, 4 (4) 359-365 10.1038/nmeth1015
53. Hotary, K. B.; Allen, E. D.; Brooks, P. C.; Datta, N. S.; Long, M. W.; Weiss, S. J. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix Cell 2003, 114 (1) 33-45 10.1016/S0092-8674(03)00513-0
54. Lutolf, M. P.; Lauer-Fields, J. L.; Schmoekel, H. G.; Metters, A. T.; Weber, F. E.; Fields, G. B.; Hubbell, J. A. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics Proc. Natl. Acad. Sci. U. S. A. 2003, 100 (9) 5413-5418 10.1073/pnas.0737381100
55. Kalluri, R.; Weinberg, R. A. The basics of epithelial-mesenchymal transition J. Clin. Invest. 2009, 119 (6) 1420-1428 10.1172/JCI39104
56. Hanahan, D.; Weinberg, R. A. Hallmarks of Cancer: The Next Generation Cell 2011, 144 (5) 646-674 10.1016/j.cell.2011.02.013
57. Xie, D.; Gore, C.; Liu, J.; Pong, R.-C.; Mason, R.; Hao, G.; Long, M.; Kabbani, W.; Yu, L.; Zhang, H.; Chen, H.; Sun, X.; Boothman, D. A.; Min, W.; Hsieh, J.-T. Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis Proc. Natl. Acad. Sci. U. S. A. 2010, 107 (6) 2485-2490 10.1073/pnas.0908133107
58. Saini, S.; Majid, S.; Yamamura, S.; Tabatabai, L.; Suh, S. O.; Shahryari, V.; Chen, Y.; Deng, G.; Tanaka, Y.; Dahiya, R. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis Clin. Cancer Res. 2011, 17 (16) 5287-5298 10.1158/1078-0432.CCR-10-2619
59. Cano, A.; Perez-Moreno, M. A.; Rodrigo, I.; Locascio, A.; Blanco, M. J.; del Barrio, M. G.; Portillo, F.; Nieto, M. A. The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression Nat. Cell Biol. 2000, 2 (2) 76-83 10.1038/35000025
60. Beach, S.; Tang, H.; Park, S.; Dhillon, A. S.; Keller, E. T.; Kolch, W.; Yeung, K. C. Snail is a repressor of RKIP transcription in metastatic prostate cancer cells Oncogene 2008, 27 (15) 2243-2248 10.1038/sj.onc.1210860
61. Liu, Y. N.; Abou-Kheir, W.; Yin, J. J.; Fang, L.; Hynes, P.; Casey, O.; Hu, D.; Wan, Y.; Seng, V.; Sheppard-Tillman, H.; Martin, P.; Kelly, K. Critical and Reciprocal Regulation of KLF4 and SLUG in Transforming Growth Factor beta-Initiated Prostate Cancer Epithelial-Mesenchymal Transition Mol. Cell. Biol. 2012, 32 (5) 941-953 10.1128/MCB.06306-11
62. Baygi, M. E.; Soheili, Z. S.; Essmann, F.; Deezagi, A.; Engers, R.; Goering, W.; Schulz, W. A. Slug/SNAI2 regulates cell proliferation and invasiveness of metastatic prostate cancer cell lines Tumor Biol. 2010, 31 (4) 297-307 10.1007/s13277-010-0037-5
63. Kwok, W. K.; Ling, M.-T.; Lee, T.-W.; Lau, T. C. M.; Zhou, C.; Zhang, X.; Chua, C. W.; Chan, K. W.; Chan, F. L.; Glackin, C.; Wong, Y.-C.; Wang, X. Up-Regulation of TWIST in Prostate Cancer and Its Implication as a Therapeutic Target Cancer Res. 2005, 65 (12) 5153-5162 10.1158/0008-5472.CAN-04-3785
64. Yuen, H. F.; Chua, C. W.; Chan, Y. P.; Wong, Y. C.; Wang, X.; Chan, K. W. Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer Histopathology 2007, 50 (5) 648-658 10.1111/j.1365-2559.2007.02665.x
65. Liu, J.; Uygur, B.; Zhang, Z.; Shao, L.; Romero, D.; Vary, C.; Ding, Q.; Wu, W.-S. Slug inhibits proliferation of human prostate cancer cells via downregulation of cyclin D1 expression Prostate 2010, 70 (16) 1768-1777 10.1002/pros.21213
66. Leshem, O.; Madar, S.; Kogan-Sakin, I.; Kamer, I.; Goldstein, I.; Brosh, R.; Cohen, Y.; Jacob-Hirsch, J.; Ehrlich, M.; Ben-Sasson, S.; Goldfinger, N.; Loewenthal, R.; Gazit, E.; Rotter, V.; Berger, R. TMPRSS2/ERG Promotes Epithelial to Mesenchymal Transition through the ZEB1/ZEB2 Axis in a Prostate Cancer Model PLoS One 2011, 6 (7) e21650 10.1371/journal.pone.0021650
67. Kong, D. J.; Li, Y. W.; Wang, Z. W.; Banerjee, S.; Ahmad, A.; Kim, H. R. C.; Sarkar, F. H. miR-200 Regulates PDGF-D-Mediated Epithelial-Mesenchymal Transition, Adhesion, and Invasion of Prostate Cancer Cells Stem Cells 2009, 27 (8) 1712-1721 10.1002/stem.101
68. Gandellini, P.; Folini, M.; Longoni, N.; Pennati, M.; Binda, M.; Colecchia, M.; Salvioni, R.; Supino, R.; Moretti, R.; Limonta, P.; Valdagni, R.; Daidone, M. G.; Zaffaroni, N. miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase C epsilon Cancer Res. 2009, 69 (6) 2287-2295 10.1158/0008-5472.CAN-08-2894
69. Yao, D.; Dai, C.; Peng, S. Mechanism of the Mesenchymal-Epithelial Transition and Its Relationship with Metastatic Tumor Formation Mol. Cancer Res. 2011, 9 (12) 1608-1620 10.1158/1541-7786.MCR-10-0568
70. De Marzo, A. M.; Knudsen, B.; Chan-Tack, K.; Epstein, J. I. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens Urology 1999, 53 (4) 707-713 10.1016/S0090-4295(98)00577-9
71. Rubin, M. A.; Mucci, N. R.; Figurski, J.; Fecko, A.; Pienta, K. J.; Day, M. L. E-cadherin expression in prostate cancer: A broad survey using high-density tissue microarray technology Hum. Pathol. 2001, 32 (7) 690-697 10.1053/hupa.2001.25902
72. Das, R.; Gregory, P. A.; Hollier, B. G.; Tilley, W. D.; Selth, L. A. Epithelial plasticity in prostate cancer: principles and clinical perspectives Trends Mol. Med. 2014, 20 (11) 643-651 10.1016/j.molmed.2014.09.004
73. Bae, K.-M.; Parker, N. N.; Dai, Y.; Vieweg, J.; Siemann, D. W. E-cadherin plasticity in prostate cancer stem cell invasion American Journal of Cancer Research 2011, 1 (1) 71-84
74. Hlubek, F.; Brabletz, T.; Budczies, J.; Pfeiffer, S.; Jung, A.; Kirchner, T. Heterogeneous expression of Wnt/β-catenin target genes within colorectal cancer Int. J. Cancer 2007, 121 (9) 1941-1948 10.1002/ijc.22916
75. Veiseh, O.; Kievit, F. M.; Fang, C.; Mu, N.; Jana, S.; Leung, M. C.; Mok, H.; Ellenbogen, R. G.; Park, J. O.; Zhang, M. Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery Biomaterials 2010, 31 (31) 8032-8042 10.1016/j.biomaterials.2010.07.016
76. Veiseh, M.; Gabikian, P.; Bahrami, S. B.; Veiseh, O.; Zhang, M.; Hackman, R. C.; Ravanpay, A. C.; Stroud, M. R.; Kusuma, Y.; Hansen, S. J.; Kwok, D.; Munoz, N. M.; Sze, R. W.; Grady, W. M.; Greenberg, N. M.; Ellenbogen, R. G.; Olson, J. M. Tumor paint: A Chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci Cancer Res. 2007, 67 (14) 6882-6888 10.1158/0008-5472.CAN-06-3948
77. Kesavan, K.; Ratliff, J.; Johnson, E. W.; Dahlberg, W.; Asara, J. M.; Misra, P.; Frangioni, J. V.; Jacoby, D. B. Annexin A2 Is a Molecular Target for TM601, a Peptide with Tumor-targeting and Anti-angiogenic Effects J. Biol. Chem. 2010, 285 (7) 4366-4374 10.1074/jbc.M109.066092
78. Lungwitz, U.; Breunig, M.; Blunk, T.; Göpferich, A. Polyethylenimine-based non-viral gene delivery systems Eur. J. Pharm. Biopharm. 2005, 60 (2) 247-266 10.1016/j.ejpb.2004.11.011
79. Kircheis, R.; Wightman, L.; Schreiber, A.; Robitza, B.; Rossler, V.; Kursa, M.; Wagner, E. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application Gene Ther. 2001, 8 (1) 28-40 10.1038/sj.gt.3301351
80. Trudel, D.; Fradet, Y.; Meyer, F.; Harel, F.; Têtu, B. Significance of MMP-2 Expression in Prostate Cancer: an Immunohistochemical Study Cancer Res. 2003, 63 (23) 8511-8515
81. Minchinton, A. I.; Tannock, I. F. Drug penetration in solid tumours Nat. Rev. Cancer 2006, 6 (8) 583-592 10.1038/nrc1893
82. Jain, R. K.; Stylianopoulos, T. Delivering nanomedicine to solid tumors Nat. Rev. Clin. Oncol. 2010, 7 (11) 653-664 10.1038/nrclinonc.2010.139
83. Liotta, L. A.; Kohn, E. C. The microenvironment of the tumour-host interface Nature 2001, 411 (6835) 375-379 10.1038/35077241
84. Cabral, H.; Matsumoto, Y.; Mizuno, K.; Chen, Q.; Murakami, M.; Kimura, M.; Terada, Y.; Kano, M. R.; Miyazono, K.; Uesaka, M.; Nishiyama, N.; Kataoka, K. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size Nat. Nanotechnol. 2011, 6 (12) 815-823 10.1038/nnano.2011.166
85. Wong, C.; Stylianopoulos, T.; Cui, J.; Martin, J.; Chauhan, V. P.; Jiang, W.; Popović, Z.; Jain, R. K.; Bawendi, M. G.; Fukumura, D. Multistage nanoparticle delivery system for deep penetration into tumor tissue Proc. Natl. Acad. Sci. U. S. A. 2011, 108 (6) 2426-2431 10.1073/pnas.1018382108
86. Sugahara, K. N.; Teesalu, T.; Karmali, P. P.; Kotamraju, V. R.; Agemy, L.; Girard, O. M.; Hanahan, D.; Mattrey, R. F.; Ruoslahti, E. Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors Cancer Cell 2009, 16 (6) 510-520 10.1016/j.ccr.2009.10.013
87. Ho, D. N.; Kohler, N.; Sigdel, A.; Kalluri, R.; Morgan, J. R.; Xu, C.; Sun, S. Penetration of Endothelial Cell Coated Multicellular Tumor Spheroids by Iron Oxide Nanoparticles Theranostics 2012, 2 (1) 66-75 10.7150/thno.3568
88. Veiseh, O.; Sun, C.; Gunn, J.; Kohler, N.; Gabikian, P.; Lee, D.; Bhattarai, N.; Ellenbogen, R.; Sze, R.; Hallahan, A.; Olson, J.; Zhang, M. Q. Optical and MRI multifunctional nanoprobe for targeting gliomas Nano Lett. 2005, 5 (6) 1003-1008 10.1021/nl0502569